
Archiv der Pharmazie p. 121 - 124 (1990)
Update date:2022-08-04
Topics:
Schwarz
Hartmann
Engel
Schneider
Schonenberger
The synthesis of the bis-acrylate 12, the bis-β-chloropropionate 13 and the bis-β-bromopropionate 14 of the 'partial' antiestrogen 2,3-bis(2-fluoro-4-hydroxyphenyl)-2,3-dimethylbutane (7) is described. In the case of 13 and 14 the introduction of the β-haloester-functions moderately reduces the estrogen receptor affinity of 7. However, it was quite strongly diminished in 12. The hydrolytic stability under in vitro-receptor-assay conditions decreases in the order 12 > 14 > 13. Compared with 7 the estrogenic potency of 12-14 is increased to a great extent. The title compounds cause a strong inhibition of the hormone-dependent MXT-M3.2 mouse mammary tumor.
View Morewebsite:http://www.chinacharm.cn/
Contact:86 551 5316260
Address:No. 211,XiangZhang Road,Hefei City,Anhui Province,China
Shanghai Coupling Pharmaceutical R&D Co., Ltd.(expird)
Contact:+86 021 50106671
Address:403 Room No.4 Buiding, No. 526 Ruiqing Road, Shanghai Zhangjiang Hi-Tech Park
Jinan Jiaquan Chemical Co.,Ltd
Contact:+86-531-62318366
Address:Room 502 of Yidonghuayuan No.601 Huaxin Road Licheng District Jinan China
Contact:86-532-68629711 13780605697
Address:NO 220 YANAN 3 ROAD,(POST ADMINISTRATION BUILDING),QINGDAO,CHINA
Nanjing Zelang Medical Technology Co. Ltd
Contact:86-25-83063290/13770714480
Address:Ganjiabian 108# 01 Unit,701-702 room,Yao Hua Street,Qixia District,Nanjing,Jiangsu,China
Doi:10.1021/jo00303a038
(1990)Doi:10.1021/om101150y
(2011)Doi:10.1021/jo00300a031
(1990)Doi:10.1016/S0040-4039(00)76195-8
(1989)Doi:10.1016/0022-328X(90)85228-Q
(1990)Doi:10.1007/BF00764814
(1989)